Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 6 May 2009, doi:10.1136/bmj.b787
Cite this as: BMJ 2009;338:b787
Their prognostic value is clear, but more research is need to define their role in treatment
| The first 150 words of the full text of this article appear below. |
Elderly patients form an increasingly large proportion of people with acute myocardial infarction, and advanced age is a strong predictor of a high risk of death or of serious complications after acute myocardial infarction.1 Paradoxically, elderly patients with acute myocardial infarction have been excluded or under-represented in most clinical trials, and limited data are available to guide their care. Studies of prognosis after acute myocardial infarction in the elderly are also scant,2 and it is unclear whether or not the established predictors of high risk of death after acute myocardial infarction in the general population are useful in the elderly.
In the linked study (doi:10.1136/bmj.b1605), Lorgis and colleagues studied a non-selected cohort of 3291 patients with acute myocardial infarction and showed that circulating concentrations of the N-terminal fragment of B type natriuretic peptide (BNP) prohormone (NT-ProBNP), had an incremental prognostic value in elderly patients, beyond established prognostic markers,
Antonio Luiz P Ribeiro, professor
1 Cardiology Service, Hospital das Clínicas, and Internal Medicine Department, Universidade Federal de Minas Gerais, 30130-100, Belo Horizonte, MG, Brazil
tom@hc.ufmg.br